151 related articles for article (PubMed ID: 33921660)
1. Identification of Novel Biomarkers and Candidate Drug in Ovarian Cancer.
Li CJ; Lin LT; Chu PY; Chiang AJ; Tsai HW; Chiu YH; Huang MS; Wen ZH; Tsui KH
J Pers Med; 2021 Apr; 11(4):. PubMed ID: 33921660
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value and Therapeutic Potential of CBX Family Members in Ovarian Cancer.
Hu K; Yao L; Xu Z; Yan Y; Li J
Front Cell Dev Biol; 2022; 10():832354. PubMed ID: 35155439
[No Abstract] [Full Text] [Related]
3. Novel gene signatures for prognosis prediction in ovarian cancer.
Bao M; Zhang L; Hu Y
J Cell Mol Med; 2020 Sep; 24(17):9972-9984. PubMed ID: 32666642
[TBL] [Abstract][Full Text] [Related]
4. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
[TBL] [Abstract][Full Text] [Related]
5. SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer.
Sun T; Bi F; Liu Z; Yang Q
Aging (Albany NY); 2020 Jul; 12(13):13281-13296. PubMed ID: 32647070
[TBL] [Abstract][Full Text] [Related]
6. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
[TBL] [Abstract][Full Text] [Related]
7. ML323 suppresses the progression of ovarian cancer
Song B; Jiang Y; Jiang Y; Lin Y; Liu J
Front Genet; 2022; 13():917481. PubMed ID: 35923700
[No Abstract] [Full Text] [Related]
8. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
[TBL] [Abstract][Full Text] [Related]
9. Luteolin inhibits colorectal cancer cell epithelial-to-mesenchymal transition by suppressing CREB1 expression revealed by comparative proteomics study.
Liu Y; Lang T; Jin B; Chen F; Zhang Y; Beuerman RW; Zhou L; Zhang Z
J Proteomics; 2017 May; 161():1-10. PubMed ID: 28391045
[TBL] [Abstract][Full Text] [Related]
10. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
Zhang L; Sun L; Zhang B; Chen L
Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence.
Sunkel B; Wu D; Chen Z; Wang CM; Liu X; Ye Z; Horning AM; Liu J; Mahalingam D; Lopez-Nicora H; Lin CL; Goodfellow PJ; Clinton SK; Jin VX; Chen CL; Huang TH; Wang Q
Nucleic Acids Res; 2016 May; 44(9):4105-22. PubMed ID: 26743006
[TBL] [Abstract][Full Text] [Related]
12. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
13. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
Wu WJ; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel biomarkers and candidate small-molecule drugs in cutaneous melanoma by comprehensive gene microarrays analysis.
Ma J; Cai X; Kang L; Chen S; Liu H
J Cancer; 2021; 12(5):1307-1317. PubMed ID: 33531976
[No Abstract] [Full Text] [Related]
15. Systematical analysis reveals a strong cancer relevance of CREB1-regulated genes.
Zheng T; Huang J; Xiang X; Li S; Yu J; Qu K; Xu Z; Han P; Dong Z; Liu Y; Xu F; Yang H; Jäättelä M; Luo Y; Liu B
Cancer Cell Int; 2021 Oct; 21(1):530. PubMed ID: 34641874
[TBL] [Abstract][Full Text] [Related]
16. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of
Wu L; Ling ZH; Wang H; Wang XY; Gui J
Cancer Biother Radiopharm; 2019 Dec; 34(10):642-649. PubMed ID: 31549859
[No Abstract] [Full Text] [Related]
18. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
19. Identification of KIF23 as a prognostic signature for ovarian cancer based on large-scale sampling and clinical validation.
Hu Y; Zheng M; Wang C; Wang S; Gou R; Liu O; Li X; Liu J; Lin B
Am J Transl Res; 2020; 12(9):4955-4976. PubMed ID: 33042400
[TBL] [Abstract][Full Text] [Related]
20. Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis.
Chhabra A; Fernando H; Watkins G; Mansel RE; Jiang WG
Oncol Rep; 2007 Oct; 18(4):953-8. PubMed ID: 17786359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
